Getinge AB
LSE:0GZV
Getinge AB
LSE:0GZV
Price:
204.3
SEK
-0.54%
Market Cap:
kr55.6B
Relative Value
The Relative Value of one
0GZV
stock under the Base Case scenario is
291.49
SEK.
Compared to the current market price of 204.3 SEK,
Getinge AB
is
Undervalued by 30%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
0GZV
Relative Value
Base Case
291.49
SEK
Undervaluation 30%
Multiples Across Competitors
0GZV Competitors Multiples
Getinge AB Competitors
Getinge AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Getinge AB
LSE:0GZV
|
55.4B SEK | 1.6 | 24.6 | 9.5 | 14.6 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
192B USD | 4.3 | 29.4 | 16.7 | 22.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.6B USD | 17.3 | 61.1 | 46.6 | 56.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
136.5B USD | 5.4 | 42.1 | 21.4 | 25.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
131.8B USD | 3.8 | 27.7 | 15.5 | 22.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
112.1B USD | 5.8 | 40.2 | 23.9 | 32.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.8B USD | 2.7 | 35.6 | 13 | 22.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46B EUR | 2 | 21.7 | 12 | 16.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.6B USD | 12 | 48.7 | 34.8 | 38.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD | 7.7 | 33.2 | 23.6 | 25.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
39.5B USD | 7.3 | 26.6 | 18.8 | 20.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
